3.0.0 4771 2023-03-22T18:49:20Z 2023-03-22T18:49:20Z House H HR 2014-05-29 113 From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. PITTS:H.R. 4771.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3, which states that Congressshall have the power ``to regulate commerce with foreignnations, and among the several states. . .''[Page H5023]]]> ssju00 Judiciary Committee Senate Standing Discharged from 2014-12-12T04:25:04Z Referred to 2014-09-16T19:30:24Z hsju00 Judiciary Committee House Standing hsju08 Crime and Federal Government Surveillance Subcommittee Discharged from 2014-09-09T20:56:13Z Referred to 2014-07-21T14:33:58Z Reported by 2014-09-15T18:59:27Z Markup by 2014-09-10T21:39:17Z Referred to 2014-05-29T14:03:05Z hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Reported by 2014-06-19T14:20:10Z Markup by 2014-06-19T14:19:49Z Referred to 2014-05-30T17:52:29Z Reported by 2014-09-15T18:39:46Z Markup by 2014-07-15T15:46:33Z Referred to 2014-05-29T14:03:00Z H. Rept. 113-587,Part 2 H. Rept. 113-587,Part 1 Designer Anabolic Steroid Control Act of 2014 113 2012 S 2014-02-11 Read twice and referred to the Committee on the Judiciary. Related bill CRS 2014-12-18 Became Public Law No: 113-260. President E40000 2 House floor actions 2014-12-18 Became Public Law No: 113-260. BecameLaw 36000 9 Library of Congress 2014-12-18 Signed by President. President E30000 2 House floor actions 2014-12-18 Signed by President. BecameLaw 36000 9 Library of Congress 2014-12-13 Presented to President. Floor E20000 2 House floor actions 2014-12-13 Presented to President. President 28000 9 Library of Congress 2014-12-12 Senate Message on Senate action sent to the House. Floor 2014-12-11 Senate Passed Senate without amendment by Unanimous Consent. Floor 2014-12-11 Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent. Floor 17000 9 Library of Congress 2014-12-11 ssju00 Judiciary Committee Senate Senate Committee on the Judiciary discharged by Unanimous Consent. (consideration: CR S6696) Discharge 2014-12-11 Senate Committee on the Judiciary discharged by Unanimous Consent.(consideration: CR S6696) Committee 14500 9 Library of Congress ssju00 Judiciary Committee 2014-09-16 ssju00 Judiciary Committee Senate Received in the Senate and Read twice and referred to the Committee on the Judiciary. IntroReferral 2014-09-15 16:07:14 Motion to reconsider laid on the table Agreed to without objection. Floor H38310 2 House floor actions 2014-09-15 16:07:12 On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7459-7460) Floor H37300 2 House floor actions 2014-09-15 16:07:12 Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H7459-7460) Floor 8000 9 Library of Congress 2014-09-15 16:00:58 DEBATE - The House proceeded with forty minutes of debate on H.R. 4771. Floor H8D000 2 House floor actions 2014-09-15 16:00:55 Considered under suspension of the rules. (consideration: CR H7459-7461) Floor H30000 2 House floor actions 2014-09-15 16:00:37 Mr. Pitts moved to suspend the rules and pass the bill, as amended. Floor H30300 2 House floor actions 2014-09-15 Placed on the Union Calendar, Calendar No. 434. Calendars H12410 2 House floor actions U00434 2014-09-15 Reported (Amended) by the Committee on Judiciary. H. Rept. 113-587, Part II. Committee H12200 2 House floor actions hsju00 Judiciary Committee 2014-09-15 Reported (Amended) by the Committee on Judiciary. H. Rept. 113-587, Part II. Committee 5000 9 Library of Congress hsju00 Judiciary Committee 2014-09-15 Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 113-587, Part I. Committee H12200 2 House floor actions hsif00 Energy and Commerce Committee 2014-09-15 Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 113-587, Part I. Committee 5000 9 Library of Congress hsif00 Energy and Commerce Committee 2014-09-10 hsju00 Judiciary Committee 1 House committee actions Ordered to be Reported (Amended) by Voice Vote. Committee 2014-09-10 hsju00 Judiciary Committee 1 House committee actions Committee Consideration and Mark-up Session Held. Committee 2014-09-09 hsju00 Judiciary Committee 1 House committee actions Subcommittee on Crime, Terrorism, Homeland Security, and Investigations Discharged. Committee 2014-07-21 hsju08 Crime and Federal Government Surveillance Subcommittee 1 House committee actions Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. Committee 2014-07-15 hsif00 Energy and Commerce Committee 1 House committee actions Ordered to be Reported (Amended) by Voice Vote. Committee 2014-07-15 hsif00 Energy and Commerce Committee 1 House committee actions Committee Consideration and Mark-up Session Held. Committee 2014-07-14 hsif00 Energy and Commerce Committee 1 House committee actions Committee Consideration and Mark-up Session Held. Committee 2014-06-19 hsif14 Health Subcommittee 1 House committee actions Forwarded by Subcommittee to Full Committee by Voice Vote . Committee 2014-06-19 hsif14 Health Subcommittee 1 House committee actions Subcommittee Consideration and Mark-up Session Held. Committee 2014-05-30 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2014-05-29 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsju00 Judiciary Committee 2014-05-29 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2014-05-29 Introduced in House IntroReferral Intro-H 9 Library of Congress 2014-05-29 Introduced in House IntroReferral 1000 9 Library of Congress P000373 Rep. Pitts, Joseph R. [R-PA-16] JOSEPH PITTS R PA R. 16 N P000034 Rep. Pallone, Frank, Jr. [D-NJ-6] FRANK PALLONE D NJ 6 2014-05-29 True C001076 Rep. Chaffetz, Jason [R-UT-3] Jason Chaffetz R UT 3 2014-06-25 False L000570 Rep. Lujan, Ben Ray [D-NM-3] Ben Lujan D NM R. 3 2014-07-08 False S001170 Rep. Shea-Porter, Carol [D-NH-1] Carol Shea-Porter D NH 1 2014-07-09 False A000369 Rep. Amodei, Mark E. [R-NV-2] Mark Amodei R NV E. 2 2014-07-09 False D000622 Rep. Duckworth, Tammy [D-IL-8] Tammy Duckworth D IL 8 2014-07-25 False Public Law 113-260 Crime and Law Enforcement Criminal procedure and sentencing Drug trafficking and controlled substances Fraud offenses and financial crimes Government information and archives Trade restrictions Crime and Law Enforcement 00 2014-05-29 Introduced in House 2014-09-18T17:58:04Z Designer Anabolic Steroid Control Act of 2014 - Amends the Controlled Substances Act to:  (1) expand the list of substances defined as "anabolic steroids"; (2) authorize the Attorney General to issue a temporary order adding a drug or other substance to the list of anabolic steroids; (3) impose enhanced criminal and civil penalties for possessing or trafficking in any anabolic steroid, or product containing an anabolic steroid, unless it bears a label clearly identifying the anabolic steroid by the nomenclature used by the International Union of Pure and Applied Chemistry; and (4) authorize the Attorney General to collect data and analyze products to determine whether they contain anabolic steroids and are properly labeled.

Specifies that a substance shall not be considered to be a drug or hormonal substance that is considered to be an anabolic steroid if it is: (1) an herb or other botanical; (2) a concentrate, metabolite, or extract of, or a constituent isolated directly from, an herb or other botanical; (3) a combination of two or more such substances (i.e., botanical or concentrate, metabolite, or extract); or (4) a dietary ingredient for purposes of the Federal Food, Drug, and Cosmetic Act. Provides that any person claiming the benefit of an exemption or exception from being considered a drug or hormonal substance shall bear the burden of providing the appropriate evidence.

]]> 36 2014-09-15 Passed House amended 2014-09-18T21:21:28Z Designer Anabolic Steroid Control Act of 2014 - Amends the Controlled Substances Act to add specified substances to the list of those included within the definition of "anabolic steroid." Provides that a drug or hormonal substance (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone) that is not listed and that is derived from, or has a chemical structure substantially similar to, an anabolic steroid that is listed, shall be considered to be an anabolic steroid for purposes of such Act if it: (1) has been created or manufactured with the intent of producing a substance that either promotes muscle growth or otherwise causes a pharmacological effect similar to that of testosterone; or (2) has been, or is intended to be, promoted in any manner suggesting that consuming it will promote any pharmacological effect similar to that of testosterone.

Prohibits a substance from being considered to be a drug or hormonal substance for purposes of such Act if it is: (1) an herb or other botanical, a concentrate, metabolite, or extract of, or a constituent isolated directly from, an herb or other botanical, or a combination of two or more such substances; or (2) a dietary ingredient for purposes of the Federal Food, Drug, and Cosmetic Act and is not anabolic or androgenic. Requires any person claiming the benefit of such an exception to bear the burden of providing the appropriate evidence.

Authorizes the Attorney General to issue an order adding a drug or other substance to the definition of "anabolic steroid" upon finding that: (1) the substance satisfies the criteria for being considered an anabolic steroid, and (2) such addition will assist in preventing abuse or misuse of the substance.

Prohibits importing, exporting, manufacturing, distributing, dispensing, or possessing with intent to manufacture, distribute, or dispense any anabolic steroid, or any product containing an anabolic steroid, unless it bears a label clearly identifying the anabolic steroid by the nomenclature used by the International Union of Pure and Applied Chemistry (IUPAC). Prescribes penalties. Sets forth an exemption from such IUPAC nomenclature requirement if such product is labeled in the manner required under the Federal Food, Drug, and Cosmetic Act, as described in this Act.

Authorizes the Attorney General to: (1) collect data and analyze products to determine whether they contain anabolic steroids and are properly labeled, and (2) publish a list of products containing an anabolic steroid that are not properly labeled.

]]> 82 2014-12-11 Passed Senate without amendment 2014-12-18T15:55:57Z (This measure has not been amended since it was passed by the House on September 15, 2014. The summary of that version is repeated here.)

Designer Anabolic Steroid Control Act of 2014 - Amends the Controlled Substances Act to add specified substances to the list of those included within the definition of "anabolic steroid." Provides that a drug or hormonal substance (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone) that is not listed and that is derived from, or has a chemical structure substantially similar to, an anabolic steroid that is listed, shall be considered to be an anabolic steroid for purposes of such Act if it: (1) has been created or manufactured with the intent of producing a substance that either promotes muscle growth or otherwise causes a pharmacological effect similar to that of testosterone; or (2) has been, or is intended to be, promoted in any manner suggesting that consuming it will promote any pharmacological effect similar to that of testosterone.

Prohibits a substance from being considered to be a drug or hormonal substance for purposes of such Act if it is: (1) an herb or other botanical, a concentrate, metabolite, or extract of, or a constituent isolated directly from, an herb or other botanical, or a combination of two or more such substances; or (2) a dietary ingredient for purposes of the Federal Food, Drug, and Cosmetic Act and is not anabolic or androgenic. Requires any person claiming the benefit of such an exception to bear the burden of providing the appropriate evidence.

Authorizes the Attorney General to issue an order adding a drug or other substance to the definition of "anabolic steroid" upon finding that: (1) the substance satisfies the criteria for being considered an anabolic steroid, and (2) such addition will assist in preventing abuse or misuse of the substance.

Prohibits importing, exporting, manufacturing, distributing, dispensing, or possessing with intent to manufacture, distribute, or dispense any anabolic steroid, or any product containing an anabolic steroid, unless it bears a label clearly identifying the anabolic steroid by the nomenclature used by the International Union of Pure and Applied Chemistry (IUPAC). Prescribes penalties. Sets forth an exemption from such IUPAC nomenclature requirement if such product is labeled in the manner required under the Federal Food, Drug, and Cosmetic Act, as described in this Act.

Authorizes the Attorney General to: (1) collect data and analyze products to determine whether they contain anabolic steroids and are properly labeled, and (2) publish a list of products containing an anabolic steroid that are not properly labeled.

]]> 49 2014-12-18 Public Law 2014-12-22T18:46:06Z (This measure has not been amended since it was passed by the House on September 15, 2014. The summary of that version is repeated here.)

Designer Anabolic Steroid Control Act of 2014 - Amends the Controlled Substances Act to add specified substances to the list of those included within the definition of "anabolic steroid." Provides that a drug or hormonal substance (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone) that is not listed and that is derived from, or has a chemical structure substantially similar to, an anabolic steroid that is listed, shall be considered to be an anabolic steroid for purposes of such Act if it: (1) has been created or manufactured with the intent of producing a substance that either promotes muscle growth or otherwise causes a pharmacological effect similar to that of testosterone; or (2) has been, or is intended to be, promoted in any manner suggesting that consuming it will promote any pharmacological effect similar to that of testosterone.

Prohibits a substance from being considered to be a drug or hormonal substance for purposes of such Act if it is: (1) an herb or other botanical, a concentrate, metabolite, or extract of, or a constituent isolated directly from, an herb or other botanical, or a combination of two or more such substances; or (2) a dietary ingredient for purposes of the Federal Food, Drug, and Cosmetic Act and is not anabolic or androgenic. Requires any person claiming the benefit of such an exception to bear the burden of providing the appropriate evidence.

Authorizes the Attorney General to issue an order adding a drug or other substance to the definition of "anabolic steroid" upon finding that: (1) the substance satisfies the criteria for being considered an anabolic steroid, and (2) such addition will assist in preventing abuse or misuse of the substance.

Prohibits importing, exporting, manufacturing, distributing, dispensing, or possessing with intent to manufacture, distribute, or dispense any anabolic steroid, or any product containing an anabolic steroid, unless it bears a label clearly identifying the anabolic steroid by the nomenclature used by the International Union of Pure and Applied Chemistry (IUPAC). Prescribes penalties. Sets forth an exemption from such IUPAC nomenclature requirement if such product is labeled in the manner required under the Federal Food, Drug, and Cosmetic Act, as described in this Act.

Authorizes the Attorney General to: (1) collect data and analyze products to determine whether they contain anabolic steroids and are properly labeled, and (2) publish a list of products containing an anabolic steroid that are not properly labeled.

]]> Designer Anabolic Steroid Control Act of 2014 Display Title Designer Anabolic Steroid Control Act of 2014 Official Title as Introduced To amend the Controlled Substances Act to more effectively regulate anabolic steroids. Introduced in House IH Short Titles as Introduced Designer Anabolic Steroid Control Act of 2014 Short Titles as Passed House Designer Anabolic Steroid Control Act of 2014 H House Short Titles as Passed Senate Designer Anabolic Steroid Control Act of 2014 S Senate Short Titles as Enacted Designer Anabolic Steroid Control Act of 2014 Enrolled Bill https://www.govinfo.gov/content/pkg/BILLS-113hr4771enr/xml/BILLS-113hr4771enr.xml Referred in Senate 2014-09-16T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-113hr4771rfs/xml/BILLS-113hr4771rfs.xml Reported in House 2014-09-15T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-113hr4771rh/xml/BILLS-113hr4771rh.xml Engrossed in House 2014-09-15T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-113hr4771eh/xml/BILLS-113hr4771eh.xml Introduced in House 2014-05-29T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-113hr4771ih/xml/BILLS-113hr4771ih.xml 2014-12-19T04:59:59Z https://www.govinfo.gov/content/pkg/PLAW-113publ260/uslm/PLAW-113publ260.xml Public Law 2014-12-18 Became Public Law No: 113-260. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.